CNBC Investing Club

Cramer's Investing Club: We are nibbling on this drug stock amid the broad market sell-off

David Ricks, CEO, Eli Lilly
Scott Mlyn | CNBC

(This article was sent first to members of the CNBC Investing Club with Jim Cramer. To get the real-time updates in your inbox, subscribe here.)

Shortly before the closing bell, we will be buying 25 shares of Eli Lilly (LLY) at roughly $243.81. Following the trade, the Charitable Trust will own 400 shares of Eli Lilly. This buy will increase Eli Lilly's weight in the portfolio from about 2.28% to 2.43%. 

More In CNBC Investing Club Newsletter

CNBC Investing ClubStocks are getting slammed — bear market or not — but the very best companies are on sale
CNBC Investing ClubWhy Jim Cramer wants the Fed to hike rates much more aggressively
CNBC Investing ClubA major slide in this tech stock allows us to be buyers again